Sophia Engelhard

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Molecular cancer therapeutics

BRIC/ University of Copenhagen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

BRIC/ University of Copenhagen Jan 01 2019

Denmark

PhD Candidate :: BRIC/ Finsen laboratory

Publications

Anders Centio, Montserrat Estruch Alrich, Kristian Reckzeh, Kumar Sanjiv, Camilla Vittori, Sophia Engelhard, Ulrika Warpman Berglund, Thomas Helleday, Kim Theilgaard-Mönch
Inhibition of Oxidized Nucleotide Sanitation By TH1579 and Conventional Chemotherapy Cooperatively Enhance Oxidative DNA Damage and Survival in AML. Molecular cancer therapeutics 21 (5) (2022)
Montserrat Estruch Alrich, Kristian Reckzeh, Camilla Vittori, Anders Centio, Mina Ali, Sophia Engelhard, Ling Zhao, Kyoung Jae Won, Paul Liu, Bo Torben Porse, Kim Theilgaard-Mönch
Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy. Leukemia 35 (7) (2020)